MelissaBrownMD

PubMed

• Cost-Utility Analysis of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.
  Gary C Brown, Melissa M Brown, Meg C Monigle> ;Ophthalmology. Retina. 2023 Nov 21
• 1 citations
  Preference-based comparison of quality of life associated with vision loss in Black and White ophthalmic populations in the US.
  Gary C Brown, Melissa M Brown, Sanjay Sharma> ;Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2024 Feb 1
• 1 citations
  Quality of life associated with no light perception vision.
  Gary C Brown, Melissa M Brown, Joshua D Stein, Sanjay Sharma> ;Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2023 Aug 1
• 10 citations
  A Cost-Benefit Analysis of VEGF-Inhibitor Therapy for Neovascular Age-Related Macular Degeneration in the United States.
  Gary C. Brown, Melissa M. Brown, Sara B. Rapuano, David S. Boyer> ;American Journal of Ophthalmology. 2021 Mar 1
• 2 citations
  Vision-related quality-of-life estimates in adolescent youths.
  Woody Stevens, Gary C. Brown, Melissa M. Brown, Joshua D. Stein, Sanjay Sharma> ;Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2021 Feb 13
• 19 citations
  Cost-Utility Analysis of VEGF Inhibitors for Treating Neovascular Age-Related Macular Degeneration.
  Gary C. Brown, Melissa M. Brown, Sara B. Rapuano, David S. Boyer> ;American Journal of Ophthalmology. 2020 Jun 19
• 1 citations
  Reply to Comment on: Cost-Effectiveness of Limited Vitrectomy for Vision Degrading Myodesopsia
  Benjamin Rostami, Jeannie Nguyen-Cuu, Gary C. Brown, Melissa A. Brown, Alfredo A. Sadun, Jerry Sebag> ;American Journal of Ophthalmology. 2020 May 1
• 5 citations
  Ethnicity and Diabetic Quality-of-Life.
  Gary C. Brown, Melissa M. Brown, Sanjay Sharma> ;The American Journal of the Medical Sciences. 2019 Aug 1
• 5 citations
  Cost-Effectiveness of Limited Vitrectomy for Vision-Degrading Myodesopsia.
  Benjamin Rostami, Jeannie Nguyen-Cuu, Gary Brown, Melissa Brown, Alfredo A Sadun, J Sebag> ;American Journal of Ophthalmology. 2019 Aug 1
• 6 citations
  Health care stakeholder perceptions of vision loss.
  Gary C. Brown, Melissa M. Brown> ;Survey of Ophthalmology. 2019 May 1
• 11 citations
  The Burden of Retinal Venous Occlusion: An Assessment of Fellow Eyes in 1000 Cases.
  Gary C. Brown, Janet Yoo, Melissa A. Brown, Adam Turpcu, Yamina Rajput, William E. Benson, Mitchell S. Fineman, David H. Fischer, Sunir J. Garg, Omesh P. Gupta, Allen ...> ;Ophthalmology. Retina. 2017 Sep 1
• 9 citations
  The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited.
  Gary C. Brown, Melissa M. Brown, Heidi B. Lieske, Adam Turpcu, Yamina Rajput> ;International Journal of Retina and Vitreous. 2017 Feb 13
• 4 citations
  Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness...
  R. Joseph Olk, Enrique Peralta, Dennis L. Gierhart, Gary C. Brown, Melissa M. Brown> ;International Journal of Retina and Vitreous. 2015 Nov 9
• 6 citations
  A Value-Based Medicine cost-utility analysis of genetic testing for neovascular macular degeneration
  Gary C. Brown, Melissa M. Brown, Heidi B. Lieske, Philip A. Lieske, Kathryn S. Brown> ;International Journal of Retina and Vitreous. 2015 Oct 26
• 19 citations
  Photopsias: A Key to Diagnosis.
  Gary C. Brown, Melissa M. Brown, David H. Fischer> ;Ophthalmology. 2015 Oct 1
• 26 citations
  The Cost-Effectiveness of Ranibizumab for the Treatment of Diabetic Macular Edema
  Gary C. Brown, Melissa M. Brown, Adam Turpcu, Yamina Rajput> ;Ophthalmology. 2015 Jul 1
• 11 citations
  Medical student and patient perceptions of quality of life associated with vision loss
  Imtiaz Chaudry, Gary C. Brown, Melissa M. Brown> ;Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2015 Jun 1
• 21 citations
  Financial return-on-investment of ophthalmic interventions: a new paradigm.
  Melissa M. Brown, Gary C. Brown, Heidi B. Lieske, P. Alexander Lieske> ;Current Opinion in Ophthalmology. 2014 May 1
• 85 citations
  Cataract Surgery Cost Utility Revisited in 2012: A New Economic Paradigm
  Gary C. Brown, Melissa M. Brown, Alicia Menezes, Brandon G. Busbee, Heidi B. Lieske, Philip A. Lieske> ;Ophthalmology. 2013 Dec 1
• 2 citations
  Healthcare costs, buyer alert.
  Melissa M. Brown, Gary C. Brown, Heidi B Leiske, P. Alexander Lieske> ;Current Opinion in Ophthalmology. 2011 May 1
• 10 citations
  Comparative effectiveness: its role in the healthcare system.
  Melissa M. Brown, Betsy Luo, Heidi C. Brown, Gary C. Brown> ;Current Opinion in Ophthalmology. 2009 May 1
• 47 citations
  Value-Based Medicine, Comparative Effectiveness, and Cost-effectiveness Analysis of Topical Cyclosporine for the Treatment of Dry Eye Syndrome
  Melissa M. Brown, Gary C. Brown, Heidi C. Brown, Jonathan Peet, Zachary Roth> ;Archives of Ophthalmology. 2009 Feb 9
• 72 citations
  A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration.
  Melissa M. Brown, Gary C. Brown, Heidi C. Brown, Jonathan Peet> ;Ophthalmology. 2008 Jun 1
• 101 citations
  Quality of life associated with visual loss: A time tradeoff utility analysis comparison with medical health states
  Melissa M. Brown, Gary C. Brown, Sanjay Sharma, Brandon G. Busbee> ;Ophthalmology. 2003 Jun 1
• 5 citations
  Health care economic analyses.
  Melissa M. Brown> ;Current Opinion in Ophthalmology. 2003 Jun 1
• Join now to see all